Controlling complement 5a (C5a) in disease setting requires a specifically targeted inhibition. (October 2018) - Guo, Renfeng; Habel, Maria; Ziereisen, Jana; Hermann, Marlen; Xu, Zhongli; Zenker, Othmar; Kirschfink, Michael; Riedemann, Niels